Published in Cancer Weekly, June 12th, 1995
Universal donor cells are cells genetically modified to avoid tissue rejection following transplantation and represent a potential approach to in vivo gene therapy for diseases such as viral infection and cancer.
The two patents issued to Cell Genesys concern genetic modifications which may be used to create certain types of universal donor cells. One of the patents covers human epithelial cells such as skin and eye cells carrying a specific genetic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.